Pharmacology, Toxicology and Pharmaceutical Science
2,5 Dimethoxy 4 Methylamphetamine
9%
3,4 Dichloro N Methyl N [2 (1 Pyrrolidinyl)cyclohexyl]benzeneacetamide
7%
4 Aminobutyric Acid
33%
4 Aminobutyric Acid Receptor
9%
8-OH-DPAT
7%
Adverse Event
11%
Agonist
41%
Amphetamine
10%
Animal
11%
Antagonist
33%
Anticonvulsive Agent
8%
Antinociception
6%
Baclofen
12%
Barbiturate
9%
Behavioral Effect
14%
Benzodiazepine
35%
Binding Site
12%
Bipolar Depression
7%
Bipolar Disorder
36%
Bipolar I Disorder
6%
Bradykinin
6%
Buprenorphine
10%
Clinical Trial
9%
Cocaine
32%
Columbidae
7%
Convulsant Agent
7%
Cosmetic
16%
Cosmetics
10%
Dependent Personality Disorder
8%
Depression
28%
Desipramine
12%
Diamorphine
10%
Diazepam
18%
Diseases
26%
Dopamine
21%
Drug
100%
Duragesic
15%
Ethanol
35%
Flumazenil
16%
Flunitrazepam
8%
Haloperidol
11%
Haplorhini
31%
IC50
7%
Insulin
6%
Ketamine
11%
Lamictal
18%
Ligand
18%
Lithium
30%
Lorcaserin
9%
Malignant Neoplasm
12%
Methylenedioxypyrovalerone
6%
Midazolam
17%
Monotherapy
8%
Mood Stabilizer
10%
Morphine
34%
Mouse
33%
Mu Opiate Receptor Agonist
6%
Nalbuphine
6%
Naloxone
6%
Naltrexone
18%
Nicotine
14%
Noradrenalin
12%
Olanzapine
11%
Opiate
38%
Opiate Agonist
15%
Opiate Receptor
16%
Paclitaxel
7%
Pain
9%
Pentobarbital
17%
Pharmacokinetics
11%
Phencyclidine
8%
Picrotoxin
8%
Placebo
22%
Protein
14%
Rat
77%
Receptor
89%
Receptor Agonist
11%
Receptor Subtype
7%
Remifentanil
6%
Rhesus Monkey
41%
Rimonabant
6%
Safety Assessment
13%
Schizophrenia
10%
Selective Serotonin Reuptake Inhibitor
12%
Serotonin
19%
Serotonin Transporter
9%
Side Effect
8%
Sodium Chloride
10%
Sodium Valproate
15%
Steroids
7%
Sulfur 35
11%
Symptom
13%
Tetrahydrocannabinol
16%
Tolerability
7%
Toxicity
7%
Tritium
24%
Tubulin
12%
Ursolic Acid
7%
Valproate Semisodium
8%
Water
7%
Neuroscience
5-HT1A Receptor
11%
5-HT2A Receptor
7%
Acetate
8%
Adiponectin
8%
Adrenocorticotropic Hormone
6%
Agonist
31%
Amphetamine
19%
Amygdala
7%
Antidepressant
23%
Antipsychotic
6%
Anxiety
17%
Baclofen
7%
Behavior (Neuroscience)
46%
Behavioral Effect
12%
Binding Site
14%
Bipolar Disorder
31%
Bipolar I Disorder
7%
Bradykinin
9%
Brain
48%
Brain-Derived Neurotrophic Factor
9%
Cannabinoid
8%
Cannabis
45%
Cell Signaling
7%
Cerebellum
12%
Cerebral Cortex
11%
Cognitive Disorders
10%
Cognitive Flexibility
9%
Comorbidity
6%
Corticosterone
6%
Dementia Praecox
27%
Dentate Gyrus
6%
Depression
39%
Desipramine
11%
Diazepam
7%
Dopamine
45%
Dopamine Receptor
6%
Drug Abuse
6%
Eicosanoid Receptor
53%
Enzymes
7%
Fat
13%
Feeding Behavior
10%
Fentanyl
7%
Fluvoxamine
6%
GABA Receptor
9%
GABAA Receptor
21%
Gamma-Aminobutyric Acid
31%
Gene
18%
Gene Expression
9%
Gonadotropin-Releasing Hormone
6%
Haloperidol
13%
Hippocampus
29%
Hypothalamus
7%
Impulsivity
9%
In Vitro
10%
In Vivo
20%
Insulin
11%
Ketamine
12%
Kynurenine
6%
L-DOPA
8%
Leptin
10%
Ligand
11%
Lithium
15%
Major Depressive Disorder
6%
Methylenedioxypyrovalerone
9%
Microglia
8%
Microtubules
9%
Morphine
25%
Naltrexone
12%
Neuron
55%
Neurotransmission
7%
Nicotine
8%
NMDA Receptor
6%
Norepinephrine
13%
Nucleus Accumbens
6%
Opioid
23%
Orbitofrontal Cortex
9%
Parkinson's Disease
14%
Pentobarbital
7%
Phencyclidine
6%
Phenotype
8%
Phosphorylation
12%
Placebo
16%
Posttraumatic Stress Disorder
6%
Prefrontal Cortex
20%
Protein
16%
Psychosis
9%
Quinpirole
9%
Radioligand
6%
Receptor Agonists
17%
Receptor Antagonist
13%
Receptor Subunit
6%
Remifentanil
11%
Selective Serotonin Reuptake Inhibitor
8%
Sensory Neuron
7%
Serotonergic
6%
Serotonin
23%
Serotonin Transporter
14%
Social Interaction
7%
Vagal Nerve Stimulation
6%
δ -Opioid Receptor
16%
Medicine and Dentistry
Adult
5%
Age
10%
Aging
6%
Agonist
11%
Alcohol
6%
Alzheimer's Disease
5%
Analysis
7%
Antagonist
6%
Antidepressant
7%
Anxiety
8%
Assessment
5%
Bipolar Disorder
41%
Bipolar I Disorder
6%
Brain
18%
Cells
22%
Chemotherapeutic Agent
24%
Combination Therapy
20%
Comprehension
5%
Depression
23%
Development
12%
Diagnosis
8%
Diseases
21%
Dopamine
11%
Drug
24%
Drug Therapy
12%
Female
5%
Gene
7%
Glucose
9%
Inpatient
6%
Insulin
9%
Insulin Resistance
11%
Insulin Sensitivity
5%
Lamotrigine
6%
Lifespan
12%
Ligand
6%
Lithium
14%
Macrophage
7%
Maintenance Therapy
5%
Major Depressive Episode
7%
Male
8%
Malignant Neoplasm
7%
Maturity Onset Diabetes of the Young
12%
Mood
9%
Morphine
7%
Neuron
15%
Noradrenalin
5%
Obesity
11%
Opiate
6%
Pain
6%
Patient
52%
Placebo
8%
Plasma
8%
Programmed Cell Death
5%
Protein
9%
Rapamycin
10%
Receptor
27%
Regulatory Mechanism
7%
Serotonin
5%
Signal Transduction
5%
Sodium Valproate
5%
Stress
11%
Symptom
20%
Therapeutic Procedure
63%
Tissues
5%
Valproate Semisodium
6%